Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

11.85
Data as of Oct 24
 -0.05 / -0.42%
Today’s Change
2.62
Today|||52-Week Range
13.09
+252.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$2.3B

Company Description

Avanir Pharmaceuticals, Inc. is a pharmaceutical company focused on acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders. The company's products are NUEDEXTA, AVP-923, Deuterated Dextromethorphan, ABREVA and Thravixa. Avanir Pharmaceuticals was founded on August 31, 1988 and headquartered in Aliso Viejo, CA.

Contact Information

Avanir Pharmaceuticals, Inc.
20 Enterprise
Aliso Viejo California 92656
P:(949) 389-6700
Investor Relations:
(949) 389-6737

Employees

Shareholders

Mutual fund holders35.43%
Other institutional29.41%
Individual stakeholders11.23%

Top Executives

Keith A. KatkinPresident, Chief Executive Officer & Director
Christine G. OcampoSecretary & Vice President-Finance
Randall E. KayeChief Medical Officer & SVP-Medical Affairs
Joao SiffertCSO, Senior VP-Research & Development
Rohan PalekarChief Commercial Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.